Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04472793 · ClinicalTrials.gov registry record
Repeated Employee Testing for Understanding Our Recovery to Normal
A clinical trial, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- 236
- Enrollment target
NCT04472793: Completed study, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT04472793 is a clinical trial that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 236 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04472793 has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- 236 participants
- Enrollment target
Study Summary
The purpose of this research study is 1) to conduct a prospective longitudinal surveillance research trial, enrolling up to 200 CCHMC employees as they come back to work, and then following their clinical and laboratory parameters for up to 12 months; and 2) to support the ongoing development of diagnostic techniques for COVID-19. The overall goal is to investigate patterns of SARS-COV-2 infection, including immunological recovery and genetic risk factors, among CCHMC employees to better understand how to safely reintroduce the CCHMC work force back into their normal routines.
Primary Outcome
Acquired COVID is defined as testing negative for COVID at baseline and having 1 or more weekly nasal swab samples testing positive for the virus by PCR
Interventions
- DIAGNOSTIC_TEST SARS-CoV-2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 236 participants |
| Start Date | 2020-05-11 |
| Est. Completion | 2023-12-31 |
What the finished NCT04472793 record still lists
NCT04472793 is an observational study that tracks outcomes without assigning an intervention. The registered 236 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which SARS-CoV-2 is the first listed.
NCT04472793 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04472793 about?
NCT04472793 is a clinical study titled "Repeated Employee Testing for Understanding Our Recovery to Normal". The purpose of this research study is 1) to conduct a prospective longitudinal surveillance research trial, enrolling up to 200 CCHMC employees as they come back to work, and then following their clinical and laboratory parameters for up to 12 months; and 2) to support the ongoing development of dia...
What is the current status of trial NCT04472793?
This trial is currently completed. The enrollment target is 236 participants. The study started on 2020-05-11. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT04472793?
The interventions under investigation include: SARS-CoV-2 (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04472793?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04995341 · 236 participants · NA
Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)
- NCT05822362 · 236 participants · Phase 2
CBD for Individuals at Risk for Alzheimer's Disease
- NCT06200103 · 236 participants · Phase 2
Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
- NCT06494072 · 236 participants · Phase 4
Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI